Fermented Papaya and Driving Simulator Older Adult Study
Launched by UNIVERSITY OF FLORIDA · Nov 1, 2024
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study, titled "Fermented Papaya and Driving Simulator Older Adult Study," investigates the association between Fermented Papaya Preparation (FPP) and driving performance in adults aged 70-80 using a high-fidelity driving simulator. With the aging population growing and driving safety as a critical issue among older adults, this study aims to determine whether FPP-a known antioxidant with anti-inflammatory properties-can enhance cognitive functions essential for safe driving, including attention, working memory, reaction time, and executive functions.
Participants will undergo three dr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 70 and 80 years.
- • Community-dwelling and independent in daily living activities.
- • Holds a valid driver's license and has driven in the last 3 months.
- • Proficient in reading, writing, and speaking English.
- • Physically able to participate in a driving simulation.
- • Willing to comply with the study requirements, including FPP dosing and simulator sessions.
- Exclusion Criteria:
- • Currently taking psychoactive medications.
- • Diagnosed with a physical disability that impairs driving ability.
- • History of upper extremity amputation or right lower extremity amputation.
- • Scores below 18/30 on the Montreal Cognitive Assessment (MoCA).
- • Exhibits symptoms of severe simulator sickness after an initial test session.
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Patients applied
Trial Officials
Sherrilene Classen, PhD, MPH
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported